Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthAetna UROD Coverage Update | OpenPayer
    Ask Trek AI about this page
    CurrentAetnaPolicy 0317

    Ultra Rapid Detoxification (UROD)

    Customize your policy alerts

    Sign up for Aetna Policy 0317 alerts

    Get alerted when Policy 0317 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Aetna's coverage stance on ultra rapid detoxification (UROD) for opioid detoxification and related indications; applies to providers and claims adjudicators handling detoxification services for Aetna members.

    Policy Summary
    PayerAetna
    PolicyUltra Rapid Detoxification (UROD)
    Policy CodePolicy 0317
    Change TypeNo material changes
    Effective DateMar 18, 1999
    Last ReviewApr 28, 2023
    Next Review DateMar 14, 2024
    Key ActionDo not provide ultra rapid detoxification (UROD); it is considered experimental/investigational and is not a covered service.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    investigationalcoverage stance for UROD
    serious AEssafety concerns reported
    1 studylimited high-quality evidence
    no codecoding note (UROD)

    Coverage Determinations

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Coverage stance — Experimental and Investigational

    Covered when ALL of the following are met:

    UROD considered investigational: Aetna considers ultra rapid detoxification (UROD) experimental and investigational as a clinical detoxification treatment and for all other indications because its effectiveness has not been established.

    The following ICD-10 diagnosis code ranges are identified in this Clinical Policy Bulletin as not covered for the indications addressed: F11.10–F11.19 (opioid abuse), F11.20–F11.29 (opioid dependence), and the listed poisoning and adverse-effect codes in the T40.x group (including but not limited to T40.0X1+–T40.4X4+, T40.601+–T40.604+, T40.691+–T40.694+, and the adverse-effect subcodes such as T40.0X5+, T40.3X5+, T40.605+, and T40.695+).

    Anesthesia-assisted or heavy-sedation ultra rapid opioid detoxification (UROD) is regarded as not medically sound because published evidence and guideline reviews report serious harms and do not demonstrate benefit. Sources note reports of serious adverse events — including deaths associated with anesthetic use and risks such as aspiration during anesthesia — and systematic reviews and guideline recommendations state that the potential harms and lack of demonstrated effectiveness do not support offering anesthesia-assisted or heavy-sedation UROD.

    Coding and Billing

    Not covered / Related codesmixedNot Covered
    J2310Injection, naloxone HCl, per 1 mg [not covered when used for UROD]
    J2311Injection, naloxone hydrochloride (zimhi), 1 mg [not covered when used for UROD]
    F11.10 - F11.19Opioid abuse
    F11.20 - F11.29Opioid dependence
    T40.0X1+ - T40.4X4+Poisoning by opiates and related narcotics (various subcodes listed)
    T40.0X5+ T40.2X5+ T40.4X5+ T40.605+ T40.695+Adverse effects of other opiates and related narcotics
    T40.3X5+Adverse effects of methadone

    Provider Responsibilities and Authorization

    Prior Authorization

    Prior authorization — investigational treatment

    Aetna considers ultra rapid detoxification (UROD) experimental and investigational and therefore not a covered service; prior authorization does not make investigational services covered.

    • Relevant HCPCS codes identified in the policy (e.g., J2310, J2311) are listed as not covered when used for UROD.
    Prior Authorization

    Prior authorization (no requirements stated)

    No prior authorization requirements for UROD are specified in the extracted sections of this Clinical Policy Bulletin.

    Step Therapy

    Preferred detoxification approaches

    Clinical guidance supports established detoxification approaches — gradual withdrawal combined with medication and long-term psychosocial support — rather than anesthesia-assisted or heavy sedation UROD.

    • Proven detoxification involves gradual withdrawal plus medication and long-term psychosocial support.
    • Guidelines and systematic reviews recommend against anesthesia-assisted rapid or ultra-rapid detoxification due to lack of benefit and risk of serious harms.
    Note

    No specified provider action

    No additional provider action or requirement is specified in the extracted policy content for this inventory item.

    Documentation Required

    Safety and evidence documentation

    Document the evidence in the clinical record if UROD is considered, including reported safety concerns, lack of demonstrated effectiveness, and referenced guideline recommendations against anesthesia-assisted UROD.

    • Include documentation of reported serious adverse events (including deaths) associated with anesthesia-assisted UROD.
    • Reference guideline statements (e.g., NICE, UpToDate) noting that anesthesia-assisted rapid/ultra-rapid detoxification is not recommended.
    Note

    Available Aetna resources

    Members and providers can access Aetna resources (glossary, mobile app, accessibility services, legal notices, FAQs, program provisions, privacy and nondiscrimination notices) via the links listed in the policy's Additional Information section.

    • Glossary and Aetna Mobile App links are provided.
    • Legal notices, privacy center, FAQs, program provisions, and accessibility services links are listed.
    Denial Risk

    Experimental/investigational — triggers denial

    Services for ultra rapid detoxification (UROD), and associated administration/billing (e.g., J2310, J2311 when used for UROD), are considered experimental/investigational and are not covered; claims for these services may be denied.

    • ICD-10 diagnosis codes listed for opioid abuse/dependence and opioid poisoning (F11.x; T40.x ranges) are identified in the policy as not covered for the CPB indications.
    • J2310 and J2311 are noted as not covered when used for UROD.
    Note

    External link disclaimer

    Links to non-Aetna websites are provided for convenience only; Aetna is not responsible for the content, accuracy, or privacy practices of linked sites.

    • External site content may not be controlled by Aetna and should not be relied on as Aetna policy guidance.

    Clinical Background

    Detoxification is an initial step in treating opioid use disorder, but it is not by itself a cure. Established, proven approaches emphasize a gradual withdrawal followed by medication-assisted treatment and long-term psychosocial support to reduce the risk of relapse. UROD differs by using rapid, antagonist-precipitated withdrawal under general anesthesia or heavy sedation with intensive care monitoring, and evidence does not establish its safety or superior long-term effectiveness compared with standard, medication-supported detoxification approaches.

    Key Definitions

    Definition: Ultra Rapid Opioid Detoxification (UROD)
    Procedure descriptionUROD is an opiate detoxification procedure induced by a bolus injection of very high-dose naloxone under general anesthesia or heavy sedation, followed by a slow infusion of low‑dose naloxone.
    Duration and settingThe active procedure is performed over approximately 4 hours in an intensive care unit (ICU) setting.
    Post-procedure carePatients require hospitalization for about 1–2 days as part of a full treatment protocol for monitoring and recovery.
    Anesthesia and monitoringProcedure is conducted under general anesthesia or heavy sedation with ICU‑level monitoring due to risks associated with anesthetic use and potential respiratory complications.
    Naloxone administrationProtocol involves an initial bolus of very high‑dose naloxone to precipitate withdrawal, followed by a slow infusion of low‑dose naloxone.
    Safety concernsReported serious adverse events including death and risks such as anesthetic overdose, aspiration, and choking have been documented, and evidence of safety and effectiveness is lacking.

    Treatment Approaches

    Medication-assisted detoxification / Psychosocial support

    Accepted treatment modalities:

    Established detoxification approaches: Proven detoxification procedures presently involve a gradual withdrawal followed by medication and long-term psychosocial support.

    Preferred over anesthesia-assisted or heavy sedation UROD due to lack of evidence of safety and effectiveness and reports of serious adverse events including death.

    Policy Summary
    PayerAetna
    PolicyUltra Rapid Detoxification (UROD)
    Policy CodePolicy 0317
    Change TypeNo material changes
    Effective DateMar 18, 1999
    Last ReviewApr 28, 2023
    Next Review DateMar 14, 2024
    Key ActionDo not provide ultra rapid detoxification (UROD); it is considered experimental/investigational and is not a covered service.
    SourceLink
    On This Page
    Coverage DeterminationsCoding and BillingProvider Responsibilities and AuthorizationClinical BackgroundKey DefinitionsTreatment Approaches